Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
68,652,138
-
Total 13F shares
-
17,503,196
-
Share change
-
+2,942,885
-
Total reported value
-
$16,482,508
-
Put/Call ratio
-
0%
-
Price per share
-
$0.94
-
Number of holders
-
43
-
Value change
-
+$2,741,386
-
Number of buys
-
16
-
Number of sells
-
17
Institutional Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q2 2025
As of 30 Jun 2025,
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,503,196 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BIOS Capital Management, LP, Nantahala Capital Management, LLC, Opaleye Management Inc., Mink Brook Asset Management LLC, VANGUARD GROUP INC, Bleichroeder LP, Voss Capital, LP, GEODE CAPITAL MANAGEMENT, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.